Table 5.
Mean self-efficacy and quality-of-life scores at follow-up and change in scores from baseline to follow-up by group status*
Mean score control | Mean score intervention | Mean change score control | Mean change score intervention | |
---|---|---|---|---|
Self-efficacy | ||||
Parent/caregiver | ||||
Treatment efficacy subscale | 22.84 (2.8) | 22.77 (2.9) | 0.44 (3.6) | 0.63 (3.2) |
Attack prevention subscale | 27.39 (2.9) | 27.73 (2.4) | 1.89 (6.7) | 2.00 (6.2) |
Asthma attack management subscale | 36.97 (3.3) | 37.25 (3.5) | ||
Total scale (range 19–95) | 87.03 (7.3) | 88.56 (6.6)a | 1.88 (8.7) | 3.58 (7.6) |
Child (all ages) | ||||
Total scale (range 0–27) | 20.32 (6.8) | 21.02 (6.8) | −0.11 (6.9) | +2.62 (6.3)b |
Quality of life | ||||
Parent/caregiver | ||||
Activity limitation subscale | 6.42 (1.0) | 6.47 (1.0) | −0.01 (1.2) | 0.20 (1.3) |
Emotional function subscale | 6.37 (0.8) | 6.49 (0.8) | 0.16 (1.0) | 0.30 (0.9) |
Total scale (range 1–7) | 6.38 (0.8) | 6.49 (0.8) | 0.11 (1.0) | 0.27 (0.9) |
Child (all ages) | ||||
Activity domain subscale | 3.51 (1.2) | 3.59 (1.2) | −0.47 (1.4) | −0.09 (1.7) |
Emotional domain subscale | 3.19 (1.4) | 2.47 (1.4) | −0.30 (1.3) | −0.32 (1.2) |
Symptom domain subscale | 3.20 (1.2) | 2.66 (1.2) | −0.28 (1.0) | −0.27 (1.1) |
Total scale (range 1–7) | 4.81 (1.5) | 5.50 (1.5) | +0.34 (1.3) | +0.40 (1.4) |
All comparisons p > 0.05.
Wilcoxon Rank Sum = 2517, p = 0.07.
t = 2.86, df = 175, p = 0.005.